Arrhythmia Classification Using Respiratory Rate of Change
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current implantable cardiac defibrillators face challenges in accurately discriminating between life-threatening ventricular arrhythmias and supraventricular tachycardias, leading to inappropriate shocks, which cause physical and emotional stress and unnecessary battery consumption.
Innovation Solution
An implantable medical device that analyzes intracardiac electrograms (IEGMs) in conjunction with respiratory pattern parameters, such as respiratory frequency and tidal volume, to classify arrhythmias accurately, using a respiratory measure that accounts for the rate of change of these parameters to determine if therapy is required.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If defibrillator uses traditional IEGM analysis alone for arrhythmia discrimination, then device complexity is low, but measurement precision of arrhythmia classification is insufficient leading to inappropriate shocks
Solution Approach 1:
The patent combines multiple discrimination techniques including IEGM analysis, respiratory pattern monitoring, interval stability assessment, and morphology analysis into a unified arrhythmia classification system. This merging of multiple sensing and analysis modalities improves measurement precision by cross-validating arrhythmia detection across different physiological parameters, reducing false positives while managing device complexity through integrated processing.
Solution Approach 2:
The patent introduces respiratory pattern parameters as an additional dimension for arrhythmia discrimination. By monitoring respiratory frequency and tidal volume changes during arrhythmia events, the system adds a new physiological dimension to the classification process, enabling better differentiation between ventricular and supraventricular tachycardias without significantly increasing device complexity.
2Reliability
If defibrillator delivers shocks for all detected tachycardias, then reliability of life-saving therapy is high, but object-affected harmful factors increase due to inappropriate shocks causing patient stress and battery consumption
Solution Approach 1:
The patent implements preliminary discrimination actions before shock delivery by analyzing multiple parameters including IEGM morphology, interval stability, and respiratory patterns. The system performs preliminary classification to determine whether detected tachycardia requires therapy, using predetermined criteria to distinguish life-threatening ventricular arrhythmias from benign supraventricular tachycardias, thereby preventing inappropriate shocks while maintaining reliable therapy delivery for true emergencies.
Solution Approach 2:
The system uses feedback from multiple sensing channels including respiratory monitors, IEGM analysis, and interval stability measurements to continuously refine arrhythmia classification. This feedback mechanism allows the device to learn from pattern recognition across multiple parameters, improving the accuracy of therapy indication decisions and reducing inappropriate shock delivery while maintaining high reliability for life-saving interventions.
Data Source
AI summary
In an implantable medical device such as an implantable cardiac defibrillator, and a method for classifying arrhythmia events, IEGM signals are analyzed to detect an arrhythmia event and a respiratory pattern of the patient is sensed. At least one respiratory parameter reflecting characteristics of the respiratory pattern of the patient is determined based on the sensed respiratory pattern and a respiratory measure corresponding to a change of a rate of change of the at least one respiratory parameter is calculated. The detected arrhythmia event is classified based on the respiratory measure and the IEGM signals, wherein arrhythmia events that satisfy at least a first criterion is classified as an arrhythmia event requiring therapy.